[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522935":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":34,"centralContacts":38,"locations":44,"responsibleParty":82,"collaborators":84,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":96,"sex":102,"minAge":103,"maxAge":10,"enrollmentInfo":104,"targetDuration":10,"studyType":107,"phases":10,"briefSummary":108,"conditions":109,"keywords":113,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Newly diagnosed gynecologic cancer",null,"Participants will undergo physical function assessments, complete surveys, and medical records every 3 months +\u002F- 4 weeks prior to standard of care surgery (outside of this protocol). After surgery subjects will be followed for at least 3 months +\u002F- 4 weeks for up to one year after diagnosis. Medical record reviews will occur periodically to examine for long-term follow up oncologic outcomes of progression free survival, overall survival, and chemotherapy delays for up to 10 years after enrollment.",[13,14,15],"Other: Physical function assessment","Other: Self-reported Assessments and Questionnaires","Procedure: Surgery (Standard of Care, Non-Interventional)",[17,21,27],{"type":6,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"Physical function assessment","Physical assessments of frailty will be conducted in person.",[9],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Self-reported Assessments and Questionnaires","Quality of life questionnaires and self-reported measures will be provided to complete during the course of the study",[9],[26],"Questionnaires",{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"PROCEDURE","Surgery (Standard of Care, Non-Interventional)","Surgical data will be reviewed via medical record",[9],[33],"Surgical Procedure",[35],{"name":36,"affiliation":5,"role":37},"Stephanie Cham, MD","PRINCIPAL_INVESTIGATOR",[39],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},"Janet Titzler","CONTACT","415-353-9600","janet.titzler@ucsf.edu",[45,65],{"facility":5,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"RECRUITING","San Francisco","California","94143","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-122.41942,37.77493,{"lat":56,"lon":55},[59,61,64],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":60},"Janet.Titzler@ucsf.edu",{"name":10,"role":41,"phone":62,"phoneExt":10,"email":63},"877-827-3222","cancertrials@ucsf.edu",{"name":36,"role":37,"phone":10,"phoneExt":10,"email":10},{"facility":66,"status":46,"city":67,"state":68,"zip":69,"country":50,"countryCode":51,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Dana Farber Cancer Institute","Boston","Massachusetts","02215",{"type":53,"coordinates":71},[72,73],-71.05977,42.35843,{"lat":73,"lon":72},[76,80],{"name":77,"role":41,"phone":78,"phoneExt":10,"email":79},"Alexi Wright, MD, MPH","617-632-2334","Alexi_Wright@dfci.harvard.edu",{"name":81,"role":37,"phone":10,"phoneExt":10,"email":10},"Alexi Wright, MD MPH",{"type":83,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[85,87,89,92],{"name":86,"class":6},"Conquer Cancer Foundation",{"name":88,"class":6},"American Society of Clinical Oncology",{"name":90,"class":91},"National Institute on Aging (NIA)","NIH",{"name":93,"class":91},"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","100522935","promoting-gynecologic-cancer-patients-with-frailty-to-achieve-functional-recovery-100522935",false,"NCT06089083","PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery","PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery - PROOF Prospective Cohort Study","PROOF","Inclusion Criteria:\n\n* Age 18 years or greater\n* Undergoing evaluation for a newly diagnosed gynecologic malignancy\n* Ability of individual or legal guardian\u002Frepresentative to understand a written informed consent document, and the willingness to sign it\n\nExclusion Criteria:\n\n* Contraindication to any study-related procedure or assessment\n* Does not speak a language for which the consent form and study materials are available","FEMALE","18 Years",{"count":105,"type":106},500,"ESTIMATED","OBSERVATIONAL","This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.",[110,111,112],"Malignant Female Reproductive System Neoplasm","Gynecologic Cancer","Gynecologic Neoplasm",[114,115],"Frailty","Risk Factors","2026-01-22",{"date":118,"type":119},"2026-01-26","ACTUAL",{"date":121,"type":119},"2023-10-18",{"date":123,"type":106},"2033-11-30",{"name":5,"class":6},2]